Key result
Withdrawal of heart failure therapy following atrial fibrillation rhythm control and ejection fraction normalization poses a clinical conundrum regarding causality in AF-mediated cardiomyopathy.
Key points are not available for this paper at this time.
Design
Editorial
No takes yet. Share an insight, caveat, or question.
This editorial discusses the management of atrial fibrillation-mediated cardiomyopathy, specifically addressing the withdrawal of heart failure therapy after rhythm control and ejection fraction normalization.
Baykaner et al. (2025) studied this question. Withdrawal of heart failure therapy following atrial fibrillation rhythm control and ejection fraction normalization poses a clinical conundrum regarding causality in AF-mediated cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: